Company intelligence / Profile preview

Pulvinar Neuro

Chapel Hill, North Carolina, USApulvinarneuro.com ↗

Ownership: Private
Employees: ~5
Development stage: Commercial

Overview

Pulvinar Neuro has developed investigational neurostimulation devices for research and potential therapeutic use. Their high-powered tACS platform is being evaluated for safety and feasibility in preclinical models and pilot human studies targeting substance use disorder. The company is preparing for further clinical development with the goal of seeking FDA clearance. No pivotal or late-stage clinical results are available yet.

Therapeutic areas: Psychiatry
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Supported by grants from NIMH and NIDA; no major pharma partnerships disclosed.

Beyond the preview

Go deeper on Pulvinar Neuro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulvinar Neuro.

Explore the full profile